Mercury in the human adrenal medulla could contribute to increased plasma noradrenaline in aging

Plasma noradrenaline levels increase with aging, and this could contribute to the sympathetic overactivity that is associated with essential hypertension and the metabolic syndrome. The underlying cause of this rise in noradrenaline is unknown, but a clue may be that mercury increases noradrenaline output from the adrenal medulla of experimental animals. We therefore determined the proportion of people from 2 to 104 years of age who had mercury in their adrenal medulla. Mercury was detected in paraffin sections of autopsied adrenal glands using two methods of elemental bioimaging, autometallography and laser ablation-inductively coupled plasma-mass spectrometry. Mercury first appeared in cells of the adrenal medulla in the 21–40 years group, where it was present in 52% of samples, and increased progressively in frequency in older age groups, until it was detected in 90% of samples from people aged over 80 years. In conclusion, the proportion of people having mercury in their adrenal medulla increases with aging. Mercury could alter the metabolism of catecholamines in the adrenal medulla that leads to the raised levels of plasma noradrenaline in aging. This retrospective autopsy study was not able to provide a definitive link between adrenal mercury, noradrenaline levels and hypertension, but future functional human and experimental studies could provide further evidence for these associations.

Effect of Stroking on Serotonin, Noradrenaline, and Cortisol Levels in the Blood of Right- and Left-Pawed Dogs

It has been assumed that stroking relieves stress responses in dogs, and dogs with the activation of the left-brain hemisphere (right-pawed) may show better adaptation to stress conditions. The aim of the study was to determine whether the stroking stimulus induced changes in the level of selected neuroregulators in dogs’ blood and whether these changes depended on the sex and the predominance of the activity of one of the brain hemispheres. The study involved 40 dogs of various breeds and both sexes. The experimental animals were subjected to a behavioral tests (Kong test), and the levels of noradrenaline, serotonin, and cortisol were determined in their blood plasma. The results of the behavioral test revealed that most dogs exhibited increased activity of the left hemisphere. Furthermore, irrespective of the sex and paw preference, stroking the animal was found to alleviate the stress response, which was reflected in reduced cortisol levels and increased serotonin levels. It was found that the plasma noradrenaline, cortisol, and serotonin levels were lower in the female dogs than in the males. Additionally, the plasma noradrenaline and serotonin levels were higher in the right-pawed dogs than in the left-pawed dogs. The present results confirm the assumption that right-pawed dogs adapt to stressful conditions more readily.

Correction: Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution

A Correction to this paper has been published: https://doi.org/10.1038/s41398-020-01102-y

EFFECTS OF LENGTH AND REGION OF SMALL INTESTINAL GLUCOSE EXPOSURE ON BLOOD PRESSURE, SUPERIOR MESENTERIC ARTERY BLOOD FLOW AND PLASMA NORADRENALINE IN HEALTHY OLDER PARTICIPANTS

Background: A substantial postprandial reduction in blood pressure (BP), triggered by the interaction of nutrients with the small intestine and associated with increases in heart rate (HR) and splanchnic blood flow, occurs frequently in healthy older people. Objective: The aim of this study was to determine whether these responses are influenced by the length and/or region of small intestine exposed to nutrients. Design: Randomized, single blind study. Setting: Clinical research laboratory. Participants: Ten healthy older participants (9M, 1F; age 65 – 79 yr). Intervention: On 3 separate study days, participants were intubated with a small intestinal catheter incorporating two duodenal infusion ports and an aspiration port, as well as an occluding balloon, which was positioned ~ 60 cm beyond the pylorus. Each participant then received a 60 min (t = 0 – 60 min) intraluminal infusion of glucose (3 kcal/min) into either the proximal (< 60 cm “GP”), or the distal (> 70 cm “GD”), or both (i.e. proximal and distal “GPD”), small intestinal segments. Measurements: BP, HR (automated device), superior mesenteric artery (SMA) blood flow (Doppler ultrasound) and plasma noradrenaline (NA). Results: Small intestinal glucose infusion was associated with reductions in systolic (GP: P = 0.004, GD: P = 0.001, GPD: P = 0.001) and diastolic (GP: P = 0.007, GD: P = 0.004, GPD: P = 0.003) BP and increases in HR (GP: P = 0.001, GD: P = 0.001, GPD: P = 0.002) and plasma NA (GP: P = 0.001, GD: P = 0.002, GPD: P = 0.001), without any difference between the three days. Conclusion: In healthy older participants, the effects of small intestinal glucose to decrease BP and increase SMA flow in healthy older participants appear to be independent of the region, or length, of small intestine exposed.